Hb. Breitz et al., MARROW TOXICITY AND RADIATION ABSORBED DOSE ESTIMATES FROM RHENIUM-186-LABELED MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 39(10), 1998, pp. 1746-1751
Estimates of radiation absorbed dose to the red marrow (RM) would be v
aluable in treatment planning for radioimmunotherapy if they could sho
w a correlation with clinical toxicity. In this study, a correlation a
nalysis was performed to determine whether estimates of radiation abso
rbed dose to the bone marrow could accurately predict marrow toxicity
in patients who had received Re-186-labeled monoclonal antibody. Metho
ds: White blood cell and platelet count data from 25 patients who rece
ived Re-186-NR-LU-10 during Phase I radioimmunotherapy trials were ana
lyzed, and the toxicity grade, the fraction of the baseline counts at
the nadir (percentage baseline) and the actual nadir were used as the
indicators of marrow toxicity. Toxicity was correlated with various pr
edictors of toxicity. These predictors included the absorbed dose to R
M, the absorbed dose to whole body (WB) and the total radioactivity ad
ministered. Results: Percentage baseline and grade of white blood cell
s and platelets all showed a moderate correlation with absorbed dose a
nd radioactivity administered (normalized for body size). The percenta
ge baseline platelet count was the indicator of toxicity that achieved
the highest correlation with the various predictors of toxicity (r =
0.73-0.79). The estimated RM absorbed dose was not a better predictor
of toxicity than either the WE dose or the total radioactivity adminis
tered. There was substantial variation in the blood count response of
the patients who were administered similar radioactivity doses and who
had similar absorbed dose estimates. Conclusion: Although there was a
moderately good correlation of toxicity with dose, the value of the d
ose estimates in predicting toxicity is limited by the patient-to-pati
ent variability in response to internally administered radioactivity.
In this analysis of patients receiving Re-186-labeled monoclonal antib
ody, a moderate correlation of toxicity with dose was observed but mar
row dose was of limited use in predicting toxicity for individual pati
ents.